In one paragraphArticle in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Ramón AsisDepartamento de Bioquímica Clínica-Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba 5000, Argentina.
Marina L FernandezCentro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA-CONICET), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba 5000, Argentina.
Gustavo BonacciDepartamento de Bioquímica Clínica-Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba 5000, Argentina.
Jose DebesDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Jhon PrietoCentro de Enfermedades Hepáticas y Digestivas (CEHYD), Bogotá 110111, Colombia.
Andre BoonstraDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.ORCID 0000-0001-8607-1616 Domingo C BalderramoHospital Privado Centro Medico de Córdoba S.A. (HPCMC), Córdoba 5000, Argentina.ORCID 0000-0001-9598-2577 Pablo A RomagnoliCentro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA-CONICET), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba 5000, Argentina.ORCID 0000-0002-6328-9070 Funding
horizon 2020, European-Latin American ESCALON consortium 825510International Atomic Energy Agency D52044, Contract Number 25058
6 · The paper itselfAbstract
Indexed as
AFB1-Lysine adductaflatoxin B1biomonitoringfood safetyhepatocellular carcinomaHPLC-MS/MSmycotoxinSouth America
Identifiers
PMID42646087
PMCPMC13514370
What OpenQuestion holds
Textmetadata
Read underepoch 390